Frequently Asked Questions about Predictive Oncology Inc. (POAI)

Name: Predictive Oncology Inc. (POAI) Institutional Financial Dataset
Creator: Olyth
License: https://olyth.xyz

Question 1

What does Predictive Oncology Inc. (POAI) do?

Accepted Answer

Predictive Oncology Inc., a knowledge-driven company, focuses on developing personalized cancer therapies using artificial intelligence (AI) primarily in the United States. The company operates in four segments: Helomics, zPREDICTA, Soluble, and Skyline. The Helomics segment offers clinical testing ...

Question 2

Is Predictive Oncology Inc. (POAI) a good stock to buy?

Accepted Answer

Olyth's institutional analysis of POAI reveals an Altman Z-Score of -24.32 and a Piotroski F-Score of 3/9. These metrics, combined with its 5-year revenue trend ($0.00B most recent), help investors decide if POAI fits their risk profile.

Question 3

What is the current P/E ratio for POAI?

Accepted Answer

As of the latest trading session, Predictive Oncology Inc. (POAI) has a trailing P/E ratio of -0.38.

Question 4

Who is the CEO of Predictive Oncology Inc.?

Accepted Answer

The current Chief Executive Officer of Predictive Oncology Inc. is Raymond F. Vennare.

Question 5

What was POAI's revenue for the last 5 years?

Accepted Answer

According to its latest income statements, Predictive Oncology Inc. reported annual revenues of $0.00B (2025), $0.00B (2024), $0.00B (2023), $0.00B (2022), $0.00B (2021) respectively.

Question 6

Does POAI pay a dividend?

Accepted Answer

Predictive Oncology Inc. does not currently pay a dividend to its shareholders.

Question 7

How much debt and cash flow does POAI have?

Accepted Answer

In its latest reporting period, Predictive Oncology Inc. generated $-0.01B in Free Cash Flow against a total debt load of $0.00B.

Question 8

What is the Price-to-Book (P/B) ratio of Predictive Oncology Inc.?

Accepted Answer

The Price-to-Book (P/B) ratio for Predictive Oncology Inc. (POAI) is currently 1.87.

Question 9

What is the Price-to-Sales (P/S) ratio of POAI?

Accepted Answer

Based on trailing twelve-month data, Predictive Oncology Inc. (POAI) trades at a Price-to-Sales (P/S) ratio of 138.41.

Question 10

What is Predictive Oncology Inc.'s Return on Equity (ROE)?

Accepted Answer

Predictive Oncology Inc. (POAI) has a Return on Equity (ROE) of 2958.98%, representing its profitability relative to shareholder equity.

Period	Revenue	Gross Profit	Op. Income	Net Income	EPS
2025-12	125.3K	52.7K	-232.9M	-233.1M	-13.37
2024-12	1.6M	797.7K	-10.9M	-12.2M	-2.24
2023-12	1.6M	1M	-12.1M	-14M	-3.48
2022-12	1.5M	1M	-26M	-25.7M	-6.98
2021-12	1.4M	933.7K	-20.4M	-19.7M	-7.16

Period	Revenue	Gross Profit	Op. Income	Net Income	EPS
2025-12	125.3K	52.7K	-232.9M	-233.1M	-13.37
2024-12	1.6M	797.7K	-10.9M	-12.2M	-2.24
2023-12	1.6M	1M	-12.1M	-14M	-3.48
2022-12	1.5M	1M	-26M	-25.7M	-6.98
2021-12	1.4M	933.7K	-20.4M	-19.7M	-7.16